Scholarly Index
Masoud Etemadifar
Isfahan University of Medical Sciences; 4,975 total citations; 321 total publications; best world rank #141
Isfahan University of Medical Sciences
4,975Total citations
321Total publications
34H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Long-Term Effects of COVID-19 | Lifetime | 632 | IR 8 | 95.68 |
| Multiple Sclerosis Research Studies | Lifetime | 470 | IR 2 | 97.21 |
| Peripheral Neuropathies and Disorders | Lifetime | 553 | IR 2 | 95.96 |
| Systemic Sclerosis and Related Diseases | Lifetime | 996 | IR 3 | 94.12 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 814 | IR 1 | 84.24 |
| Multiple Sclerosis Research Studies | 2021-2025 | 141 | IR 4 | 97.73 |
| Long-Term Effects of COVID-19 | 2021-2025 | 872 | IR 15 | 93.55 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 337 | IR 3 | 91.30 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 528 | IR 3 | 89.32 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 218 | IR 2 | 84.36 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 774 | IR 9 | 83.21 |
| Polyomavirus and related diseases | 2021-2025 | 543 | IR 5 | 79.45 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 828 | IR 20 | 70.16 |